US OptionsDetailed Quotes

NVS241220C100000

Watchlist

0.55
-0.25-31.25%

15min DelayClose Dec 13 16:00 ET

0.60High0.53Low

Novartis AG Stock Discussion

Asherboy88

Dec 11 08:09

$Novartis AG (NVS.US)$ what is happening ?? keeps going down

Movers and Shakers

Nov 21 07:11

Columns Today's Pre-Market Movers and Top Ratings | MSTR, NVDA, SNOW, PANW and More

Morning Movers
Gapping up
$Deere (DE.US)$ 's stock rose by 1.6% following their announcement of fourth-quarter earnings that surpassed analyst forecasts, despite substantial market hurdles.
Cryptocurrency-related stocks experienced a widespread surge. $MicroStrategy (MSTR.US)$ saw a significant increase, jumping over 13%, while $MARA Holdings (MARA.US)$ climbed more than 11%.
$Snowflake (SNOW.US)$ 's shares surged 23.3% as ...

Bitcoin breaks the $100,000 again: How high could it go?

10xStockPicks

Nov 15 08:23

ESPR Will Propel Higher, Events This Weekend & Analyst Event Next Week, Stock Price

This $2 Stock Remains Deeply Undervalued, Profitable in 2025, Offers 10x Upside within 20 Months
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...

+18

thz stock ful of sht

Nov 15 01:20

DOWN

$Eli Lilly and Co (LLY.US)$ $Novo-Nordisk A/S (NVO.US)$ $Johnson & Johnson (JNJ.US)$ $AbbVie (ABBV.US)$ $Merck & Co (MRK.US)$ $ROCHE HOLDING AG (RHHBY.US)$ $Novartis AG (NVS.US)$ $AstraZeneca (AZN.US)$ $Amgen (AMGN.US)$ $Pfizer (PFE.US)$

10xStockPicks

Nov 8 08:28

This $2 Stock Remains Deeply Undervalued, Profitable in 2025, Offers 10x Upside within 20 Months

Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary...

+18

Asherboy88

Nov 5 09:58

$Novartis AG (NVS.US)$ Why it keeps dropping ? didn't see any bad news

Stock_Drift

Oct 18 05:56

$Novartis AG (NVS.US)$

Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer

Growth Investor27

Oct 15 09:01

Buyout offer Could be $10+ For Esperion And Could Happen Before 2025

$Esperion Therapeutics (ESPR.US)$ The recent analyst note from Jeff sugest Esperion might sell the entire rights for Bempedoic Acid. Fair valuation on the rights would be above $1.5 billion, based on future milestones $900 million, future royalties & patents, the current formulation patent has exp date Dec 2031. The potential yearly sales in the U.S could reach $4 billion by 2027.
Esperion could also partner in the U.S .
Keep an...

TerenceFung

Oct 15 00:59

Fuiyoh~ first day all green!

Haha... a good start! I never been good with trading, will see how this end

Learn. Trade. Win: Dive into our Global Paper Trading Challenge now!

Moomoo News Global

Sep 19 07:24

Columns Will Rate Cuts Boost the Stock Market? A Global Equity Investment Guide

The Federal Reserve on Wednesday implemented its first rate cut in over four years, reducing the benchmark rate by 50 basis points to a range of 4.75%-5%.
The move surpassed Wall Street's expectations. Analysts had generally anticipated a 25 basis point cut, while the futures market had priced in a 61% probability of a 50 basis point cut and a 39% probability of a 25 basis point reduction.
Market Response to First Rate Cut
St...

Another 25bp Rate Cut! What's next for the market?

No comment yet